生物正交化学
化学
组合化学
区域选择性
催化作用
前药
级联反应
戒指(化学)
环异构化
分子内力
点击化学
药物发现
化学生物学
烷基化
喹啉酮
立体化学
可药性
复分解
生物化学
癌细胞
纳米技术
免疫结合物
化学选择性
活动站点
咪唑吡啶
卟啉
作者
Damian Alexander Graf,Nicole Rathfelder,Boris V. Lozhkin,Thomas R. Ward
摘要
Selective drug activation in living systems remains a central challenge in targeted cancer therapy. Bioorthogonal catalysis addresses this by using abiotic transition-metal catalysts to unmask prodrugs at the tumor site, but the repertoire of suitable reactions remains limited. Here, we exploit the Buchner ring-expansion as a new uncaging strategy, in which a metal-carbene catalyzes a regioselective intramolecular ring-expansion followed by spontaneous 1,6-elimination to release a caged payload─a cascade with no biological equivalent. The iridium porphyrin complex [Ir(mPIX)Me] catalyzes this reaction at nanomolar concentrations, and the platform can accommodate structurally diverse payloads. As a proof of concept, functionalization with a bivalent human carbonic anhydrase IX (hCA IX) inhibitor enabled tumor-selective release of epirubicin (Epi) in a cancer cell model. This work thus delineates a new reaction class to the growing toolkit of transition-metal-mediated bioorthogonal chemistry.
科研通智能强力驱动
Strongly Powered by AbleSci AI